Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4062321
Max Phase: Preclinical
Molecular Formula: C27H22BrClN2O2
Molecular Weight: 441.94
Molecule Type: Small molecule
Associated Items:
ID: ALA4062321
Max Phase: Preclinical
Molecular Formula: C27H22BrClN2O2
Molecular Weight: 441.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)C[n+]2ccc3c4ccccc4n(Cc4ccc(Cl)cc4)c3c2)cc1.[Br-]
Standard InChI: InChI=1S/C27H22ClN2O2.BrH/c1-32-22-12-8-20(9-13-22)27(31)18-29-15-14-24-23-4-2-3-5-25(23)30(26(24)17-29)16-19-6-10-21(28)11-7-19;/h2-15,17H,16,18H2,1H3;1H/q+1;/p-1
Standard InChI Key: TVRJYTPCIHNMKE-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.94 | Molecular Weight (Monoisotopic): 441.1364 | AlogP: 5.68 | #Rotatable Bonds: 6 |
Polar Surface Area: 35.11 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.56 | CX LogD: 1.56 |
Aromatic Rings: 5 | Heavy Atoms: 32 | QED Weighted: 0.25 | Np Likeness Score: -0.70 |
1. Venkataramana Reddy PO, Mishra S, Tantak MP, Nikhil K, Sadana R, Shah K, Kumar D.. (2017) Design, synthesis and in vitro cytotoxicity studies of novel β-carbolinium bromides., 27 (6): [PMID:28254167] [10.1016/j.bmcl.2017.02.010] |
Source(1):